Clonal analysis of invasive pneumococcal isolates in Scotland and coverage of serotypes by the licensed conjugate polysaccharide pneumococcal vaccine: Possible implications for UK vaccine policy

European Journal of Clinical Microbiology and Infectious Diseases

Volumn 24, Issue 4, 2005, Pages 262-267

  McChlery, S M ^a   Scott, K J ^a   Clarke, S C ^a,b  

^a Scottish Meningococcus and Pneumococcus Reference Laboratory   (United Kingdom)

^b UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

PNEUMOCOCCUS VACCINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATE; CONTROLLED STUDY; HEALTH CARE POLICY; HUMAN; INFANT; MULTILOCUS SEQUENCE TYPING; NONHUMAN; PRESCHOOL CHILD; PRIORITY JOURNAL; SEROTYPE; SPECIES INVASION; STREPTOCOCCUS PNEUMONIAE; UNITED KINGDOM; VACCINATION;

CHILD, PRESCHOOL; GREAT BRITAIN; HUMANS; IMMUNIZATION PROGRAMS; PNEUMOCOCCAL INFECTIONS; PNEUMOCOCCAL VACCINES; SCOTLAND; SEROTYPING; STREPTOCOCCUS PNEUMONIAE;

EID: 20044365426     PISSN: 09349723     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10096-005-1313-y     Document Type: Article

References (32)

1. Eskola J, Kilpi T, Palmu A, Jokinen J, Haapakoski J, Herva E, Takala A, Kayhty H, Karma P, Kohberger R, Siber G, Makela PH (2001) Efficacy of a pneumococcal conjugate vaccine against acute otitis media. N Engl J Med 344:403-409
2. Gertz RE Jr, McEllistrem MC, Boxrud DJ, Li Z, Sakota V, Thompson TA, Facklam RR, Besser JM, Harrison LH, Whitney CG, Beall B (2003) Clonal distribution of invasive pneumococcal isolates from children and selected adults in the United States prior to 7-valent conjugate vaccine introduction. J Clin Microbiol 41:4194-4216
3. Whitney CG, Farley MM, Hadler J, Harrison LH, Bennett NM, Lynfield R, Reingold A, Cieslak PR, Pilishvili T, Jackson D, Facklam RR, Jorgensen JH, Schuchat A (2003) Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med 348:1737-1746
4. Black SB, Shinefield HR, Hansen J, Elvin L, Laufer D, Malinoski F (2001) Postlicensure evaluation of the effectiveness of seven valent pneumococcal conjugate vaccine. Pediatr Infect Dis J 20:1105-1107
5. Murphy TV, White KE, Pastor P, Gabriel L, Medley F, Granoff DM, Osterholm MT (1993) Declining incidence of Haemophilus influenzae type b disease since introduction of vaccination. JAMA 269:246-248
6. Maiden MC, Stuart JM (2002) Carriage of serogroup C meningococci 1 year after meningococcal C conjugate polysaccharide vaccination. Lancet 359:1829-1831
7. Mooney JD, Christie P, Robertson C, Clarke SC (2004) The impact of meningococcal serogroup C conjugate vaccine in Scotland. Clin Infect Dis 39:349-356
8. Ramsay ME, Andrews NJ, Trotter CL, Kaczmarski EB, Miller E (2003) Herd immunity from meningococcal serogroup C conjugate vaccination in England: database analysis. BMJ 326:365-366
9. Spratt BG, Greenwood BM (2000) Prevention of pneumococcal disease by vaccination: does serotype replacement matter? Lancet 356:1210-1211
10. O'Brien KL, Dagan R (2003) The potential indirect effect of conjugate pneumococcal vaccines. Vaccine 21:1815-1825
11. Dagan R, Melamed R, Muallem M, Piglansky L, Greenberg D, Abramson O, Mendelman PM, Bohidar N, Yagupsky P (1996) Reduction of nasopharyngeal carriage of pneumococci during the second year of life by a heptavalent conjugate pneumococcal vaccine. J Infect Dis 174:1271-1278
12. Dagan R, Muallem M, Melamed R, Leroy O, Yagupsky P (1997) Reduction of pneumococcal nasopharyngeal carriage in early infancy after immunization with tetravalent pneumococcal vaccines conjugated to either tetanus toxoid or diphtheria toxoid. Pediatr Infect Dis J 16:1060-1064
13. Dagan R, Givon-Lavi N, Zamir O, Sikuler-Cohen M, Guy L, Janco J, Yagupsky P, Fraser D (2002) Reduction of nasopharyngeal carriage of Streptococcus pneumoniae after administration of a 9-valent pneumococcal conjugate vaccine to toddlers attending day care centers. J Infect Dis 185:927-936
14. Dagan R, Givon-Lavi N, Zamir O, Fraser D (2003) Effect of a nonavalent conjugate vaccine on carriage of antibiotic-resistant Streptococcus pneumoniae in day-care centers. Pediatr Infect Dis J 22:532-540
15. Mbelle N, Huebner RE, Wasas AD, Kimura A, Chang I, Klugman KP (1999) Immunogenicity and impact on nasopharyngeal carriage of a nonavalent pneumococcal conjugate vaccine. J Infect Dis 180:1171-1176
16. Obaro SK, Adegbola RA, Banya WA, Greenwood BM (1996) Carriage of pneumococci after pneumococcal vaccination. Lancet 348:271-272
17. Obaro SK, Adegbola RA, Chang I, Banya WA, Jaffar S, McAdam KW, Greenwood BM (2000) Safety and immunogenicity of a nonavalent pneumococcal vaccine conjugated to CRM197 administered simultaneously but in a separate syringe with diphtheria, tetanus and pertussis vaccines in Gambian infants. Pediatr Infect Dis J 19:463-469
18. Brueggemann AB, Griffiths DT, Meats E, Peto T, Crook DW, Spratt BG (2003) Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. J Infect Dis 187:1424-1432
19. Clarke SC, Scott KJ, McChlery SM (2004) Serotypes and sequence types of pneumococci causing invasive disease in Scotland prior to the introduction of pneumococcal conjugate polysaccharide vaccines. J Clin Microbiol 42:4449-4452
20. Maiden MC, Bygraves JA, Feil E, Morelli G, Russell JE, Urwin R, Zhang Q, Zhou J, Zurth K, Caugant DA, Feavers IM, Achtman M, Spratt BG (1998) Multilocus sequence typing: a portable approach to the identification of clones within populations of pathogenic microorganisms. Proc Natl Acad Sci U S A 95:3140-3145
21. Enright MC, Spratt BG (1998) A multilocus sequence typing scheme for Streptococcus pneumoniae: identification of clones associated with serious invasive disease. Microbiology 144:3049-3060
22. Jefferies J, Clarke SC, Diggle MA, Smith A, Dowson C, Mitchell T (2003) Automated pneumococcal MLST using liquid-handling robotics and a capillary DNA sequencer. Mol Biotechnol 24:303-308
23. Kyaw MH, Christie P, Clarke SC, Mooney JD, Ahmed S, Jones IG, Campbell H (2003) Invasive pneumococcal disease in Scotland, 1999-2001: use of record linkage to explore associations between patients and disease in relation to future vaccination policy. Clin Infect Dis 37:1283-1291
24. Smart LE (1986) Serotyping of Streptococcus pneumoniae strains by coagglutination. J Clin Pathol 39:328-331
25. Clarke SC, Diggle MA, Edwards GF (2001) Semiautomation of multilocus sequence typing for the characterization of clinical isolates of Neisseria meningitidis. J Clin Microbiol 39:3066-3071
26. Kyaw MH, Clarke S, Edwards GF, Jones IG, Campbell H (2000) Serotypes/groups distribution and antimicrobial resistance of invasive pneumococcal isolates: implications for vaccine strategies. Epidemiol Infect 125:561-572
27. Hausdorff WP, Bryant J, Paradiso PR, Siber GR (2000) Which pneumococcal serogroups cause the most invasive disease: implications for conjugate vaccine formulation and use, part I. Clin Infect Dis 30:100-121
28. Coffey TJ, Enright MC, Daniels M, Morona JK, Morona R, Hryniewicz W, Paton JC, Spratt BG (1998) Recombinational exchanges at the capsular polysaccharide biosynthetic locus lead to frequent serotype changes among natural isolates of Streptococcus pneumoniae. Mol Microbiol 27:73-83
29. Meats E, Brueggemann AB, Enright MC, Sleeman K, Griffiths DT, Crook DW, Spratt BG (2003) Stability of serotypes during nasopharyngeal carriage of Streptococcus pneumoniae. J Clin Microbiol 41:386-392
30. Nesin M, Ramirez M, Tomasz A (1998) Capsular transformation of a multidrug-resistant Streptococcus pneumoniae in vivo. J Infect Dis 177:707-713
31. Robinson DA, Briles DE, Crain MJ, Hollingshead SK (2002) Evolution and virulence of serogroup 6 pneumococci on a global scale. J Bacteriol 184:6367-6375
32. Feil EJ, Smith JM, Enright MC, Spratt BG (2000) Estimating recombinational parameters in Streptococcus pneumoniae from multilocus sequence typing data. Genetics 154:1439-1450